Tropomyosin receptor kinase inhibitor for treatment for inherited CYLD defective skin tumours.

A protein "scaffold" derived from fibronectin type III.

Pegylated (r-G-CSF) conjugated to polyethylene glycol for treatment of neutropenic patients with non-myeloid malignancies who are at high risk for infection.

NCI: pegfilgrastim. A long-acting pegylated form of a recombinant therapeutic agent which is chemically identical to or similar to an endogenous human granulocyte colony-stimulating factor (G-CSF). Produced endogenously by monocytes, fibroblasts, and endothelial cells, G-CSF binds to and activates specific cell surface receptors, stimulating neutrophil progenitor proliferation and differentiation and selected neutrophil functions. Conjugation of the cytokine with a branched polyethylene glycol molecule (pegylation) significantly increases its therapeutic half-life. (NCI Thesaurus)

A pegylated form of recombinant human interleukin-10.

Erythropoiesis stimulating agent for treatment of anemia of chronic renal failure.

Erythropoiesis stimulating agent for treatment of anemia of chronic renal failure.

Erythropoiesis stimulating agent for treatment of anemia of chronic renal failure.

Erythropoiesis stimulating agent for treatment of anemia of chronic renal failure.

Interferon alfa-2A chemically modified by the covalent attachment of a polyethylene glycol.

NCI: A covalent conjugate of recombinant interferon alpha, subtype 2b, and polyethylene glycol (PEG), used as an antiviral and antineoplastic agent. The biological activity of this agent is derived from its interferon alpha-2b protein moiety. more ...(NCI Thesaurus)